Rula

Telehealth platform for mental health services

Los Angeles, California, United States

About Rula

Rula operates in the telehealth market, focusing on mental health services. The platform helps individuals find suitable therapists by matching them based on their preferences, insurance information, and specific needs. Rula partners with major insurance carriers to offer affordable mental healthcare, making it accessible to a wider audience. The company has a network of over 8,000 licensed therapists, ensuring high-quality care through thorough background checks and clinical reviews. Clients can connect with therapists via live video sessions, providing convenience and flexibility. Rula's goal is to simplify the process of accessing mental health support and to make therapy more affordable for everyone.

Los Angeles, CaliforniaHeadquarters

2019Year Founded

$107.9MTotal Funding

SERIES_BCompany Stage

Enterprise Software, HealthcareIndustries

201-500Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Remote Work Options

401(k) Retirement Plan

Paid Vacation

Paid Sick Leave

Paid Parental Leave

Mental Health Support

Home Office Stipend

Phone/Internet Stipend

Wellness Program

Risks

Increased competition from telehealth startups may erode Rula's market share.

Rapid provider network expansion could challenge consistent quality of care.

Reliance on insurance partnerships risks changes in reimbursement policies.

Differentiation

Rula offers a network of over 10,000 diverse, licensed mental health providers.

Rula's partnerships with major insurers ensure affordable care for over 120 million people.

Rula provides next-day therapy availability and 24/7 crisis support across the U.S.

Upsides

Partnership with Amino Health expands Rula's reach and patient acquisition potential.

Collaboration with Amazon enhances visibility and accessibility for mental health services.

Doug Newton's appointment as CMO strengthens clinical strategies and patient care quality.

Funding

Total raised$107.88 M

Latest valuation$440.00 M

StageSERIES_B

SERIES B

12/31/2021

$88

$440.00 M

SERIES A

3/31/2021

$18

$87.50 M

SEED

9/30/2019

$27.00 M